Platelets may also play a role in tumor growth once anti-angiogenic therapy is discontinued; discontinuation of anti-VEGF medications is associated with accelerated tumor growth and simultaneous tumor platelet infiltration, while platelet depletion mitigates these effects in vivo [199]. The gene discussed is VEGFA; the disease is neoplasm.